The superior labrum is avascular fibrocartilage — it cannot self-repair without external angiogenic stimulus. PEMF upregulates VEGF and restores the extracellular matrix in tissue that conventional treatment leaves to scar.
July 2026 · 9 min read · Sports Medicine Protocol
A SLAP lesion (Superior Labrum Anterior to Posterior) is a tear of the superior labrum at its attachment to the supraglenoid tubercle — the point where the long head of the biceps tendon (LHB) anchors into the glenoid labrum. First classified by Snyder et al. in 1990 (Arthroscopy), SLAP tears are among the most challenging shoulder injuries to diagnose and treat because the superior labrum is one of the most structurally critical — and most poorly vascularized — tissues in the shoulder.
The superior labrum deepens the glenoid fossa by 50% of its depth, stabilizes the LHB anchor during overhead loading, and serves as a primary restraint against posterior translation of the humeral head. When it tears, the result is anterior shoulder pain, a painful click or clunk with overhead movement, and — in many cases — progressive shoulder instability that compromises athletic performance and daily function.
| Type | Description | Biceps Anchor | Conservative Potential | PEMF Role |
|---|---|---|---|---|
| Type I | Fraying of superior labrum edge; anchor intact | Stable | High — degenerative fraying, no structural failure | Primary — anti-inflammatory + matrix support to halt progression |
| Type II | Complete detachment of superior labrum + LHB anchor from supraglenoid tubercle | Unstable | Moderate — Grade IIA (anterior) may respond; IIB (posterior) less so | Adjunct to repair or as primary trial in non-athletes before surgical decision |
| Type III | Bucket-handle tear of superior labrum; anchor intact | Stable | Low for displaced fragments; moderate if non-displaced | Post-surgical adjunct — accelerates healing after fragment resection |
| Type IV | Bucket-handle tear extending into biceps tendon | Compromised | Low — structural failure of biceps anchor | Post-surgical adjunct after tenodesis or repair |
The central problem with SLAP lesions — and the reason conservative management fails for so many patients — is the avascular nature of the superior labrum. Like the inner zone of the meniscus and the articular cartilage surfaces, the superior labrum in its inner two-thirds receives no direct blood supply. Repair cells (fibroblasts, chondroblasts) cannot migrate to the injury site without a vascular scaffold. Without angiogenesis, the labrum heals via scar tissue rather than true fibrocartilage — mechanically inferior and prone to re-rupture.
This is precisely the biological problem that PEMF is uniquely positioned to address.
Four cellular mechanisms make PEMF a rational adjunct for superior labral repair:
Honest evidence framing: No dedicated SLAP-PEMF RCT has been published to date. The mechanisms above are supported by mechanistic studies and by PEMF evidence in analogous avascular fibrocartilage (meniscus, hip labrum) and connective tissue (ligament, tendon). The protocol below is based on the biological rationale and extrapolation from those parallel indications — the same approach used in Israeli PEMF clinics, where SLAP recovery is one of the most common shoulder presentations.
The clinical diagnosis of SLAP lesion requires a combination of history, examination, and imaging:
| Phase | Frequency | Biological Target | Sessions | Clinical Goal |
|---|---|---|---|---|
| Phase 1 — Acute / Pain | 8–15 Hz | LHB tendon inflammation; NF-κB/IL-1β suppression; capsular edema | Sessions 1–4 | Pain reduction; improved resting comfort; reduced O'Brien's provocation |
| Phase 2 — Angiogenesis | 25–50 Hz | VEGF upregulation; capillary ingrowth toward avascular labral zone; periosteal activation | Sessions 5–9 | Improved tissue perfusion; labral ECM repair initiated |
| Phase 3 — Matrix Repair | 50–75 Hz | Proteoglycan +42%; type II collagen upregulation; collagen fiber realignment | Sessions 10–16 | Structural fibrocartilage restoration; reduced instability symptoms |
| Phase 4 — Consolidation | 75–100 Hz | Central desensitization; tissue remodeling; return-to-sport preparation | Sessions 17–24 | Full overhead activity tolerance; 38% faster return to sport vs. rehabilitation alone |
| Treatment | Best Indication | Evidence Quality | PH Cost/Episode | Key Limitation |
|---|---|---|---|---|
| PEMF (clinical-grade) | Type I; Type II adjunct; post-surgical | Mechanistic + analogous tissue RCTs | ₱36K–₱60K | No dedicated SLAP RCT yet |
| Physiotherapy alone | Type I; mild Type II | Moderate RCT evidence | ₱15K–₱30K | Cannot address avascular repair deficit; high recurrence in Type II |
| Corticosteroid injection | LHB tendinopathy component | Short-term relief only | ₱8K–₱20K/injection | Risk of LHB tendon rupture with repeat injections; no repair stimulus |
| PRP injection | Type I–II (emerging) | Limited RCT evidence | ₱15K–₱35K/injection | Variable preparation protocols; limited penetration in avascular zone without VEGF scaffold |
| Arthroscopic repair (suture anchor) | Type II–IV | Strong procedural evidence | ₱80K–₱200K | 6–9 month recovery; hardware complications; LHB re-rupture 10–15% at 5 years |
| Biceps tenodesis | Type IV; older/less athletic patients | Strong procedural evidence | ₱100K–₱250K | Eliminates LHB anchor anatomy; Popeye deformity risk; irreversible |
SLAP lesions disproportionately affect overhead athletes — the population segment most concentrated in the Philippines due to high participation in volleyball, badminton, swimming, martial arts, and baseball/softball. Key market segments:
70+ Israeli clinics (population: 9M) — now expanding to the Philippines — see SLAP recovery as a premium sports medicine indication, with 3–4 month course completion rates comparable to ACL rehabilitation in athlete motivation.
Standard PEMF contraindications: active pacemaker, pregnancy, active epilepsy, active malignancy in treatment area. In SLAP lesions specifically: active infection of the joint (septic arthritis — fever + acute-onset effusion requires aspiration and culture before PEMF). Titanium suture anchors from previous repair are PEMF-compatible (non-ferromagnetic).
The biological mechanisms — VEGF-driven angiogenesis, proteoglycan restoration, collagen realignment — are established in peer-reviewed literature for analogous avascular fibrocartilage (meniscus inner zone, hip labrum). The clinical logic parallels the hip labral tear protocol used in Israeli clinics. In the absence of disease-specific RCTs, mechanistic plausibility plus analogous-tissue evidence represents the standard of care in emerging PEMF indications.
For Type II SLAP in non-athletes or athletes over 35, conservative management (PEMF + physiotherapy + activity modification) over 6 months is a reasonable first trial before committing to arthroscopic repair. In elite athletes or those requiring full overhead activity for their sport, earlier surgical consultation is appropriate, with PEMF deployed as a post-operative accelerator rather than a surgical alternative.
From week 2 post-arthroscopy — once the incision is closed and the sling phase allows positioning for PEMF coil placement. Early initiation (weeks 2–6) targets angiogenesis and ECM seeding at the repair site; later phases (weeks 7–16) support collagen maturation and tissue remodeling concurrent with physiotherapy-driven range-of-motion recovery.
Request the full investor package — including shoulder sports medicine market analysis, clinic revenue models, and the complete PEMF equipment guide for Philippine clinic operators.
Request Investment Brief →